Lantheus Holdings, Inc.

$96.09+3.44%(+$3.20)
TickerSpark Score
79/100
Solid
73
Valuation
95
Profitability
25
Growth
100
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LNTH research report →

52-Week Range96% of range
Low $47.25
Current $96.09
High $98.27

Companywww.lantheus.com

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors.

CEO
Mary Anne Heino
IPO
2015
Employees
808
HQ
Bedford, MA, US

Price Chart

+25.07% · this period
$96.67$73.39$50.11May 20Nov 18May 20

Valuation

Market Cap
$6.26B
P/E
22.29
P/S
4.05
P/B
5.13
EV/EBITDA
15.56
Div Yield
0.00%

Profitability

Gross Margin
60.48%
Op Margin
18.76%
Net Margin
18.05%
ROE
24.33%
ROIC
10.75%

Growth & Income

Revenue
$1.54B · 0.50%
Net Income
$233.56M · -25.25%
EPS
$3.46 · -23.45%
Op Income
$310.83M
FCF YoY
-28.20%

Performance & Tape

52W High
$98.27
52W Low
$47.25
50D MA
$83.01
200D MA
$66.29
Beta
-0.08
Avg Volume
1.00M

Get TickerSpark's AI analysis on LNTH

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 14, 26McHugh Julieother4,137
May 14, 26Morrow Phuong Khanhother4,137
May 14, 26Maeusli Heinz Christophother4,137
May 14, 26LENO SAM Rother4,137
May 14, 26Pruden Gary Jother4,137
May 14, 26Baylor-Henry Minnieother4,137
May 14, 26Ber Gerardother4,137
May 14, 26Thrall James Hother4,137
May 14, 26EASTLAND JULIA MARIEother4,137
Apr 17, 26Niedzwiecki Danielother1,911

Our LNTH Coverage

We haven't published any research on LNTH yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate LNTH Report →

Similar Companies